Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,769Revenue $M939Net Margin (%)4.2Z-Score3.1
Enterprise Value $M2,060EPS $0.7Operating Margin %5.5F-Score7
P/E(ttm))45.7Cash Flow Per Share $2.6Pre-tax Margin (%)4.4Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %3.6Quick Ratio2.2Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %-2.3Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow15.8y-y EBITDA Growth Rate %24.4ROA % (ttm)2.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M51.4ROI % (ttm)2.1Gross Margin Increase y-yY

Gurus Latest Trades with HAE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HAEJean-Marie Eveillard 2014-06-30 Sold Out $30.36 - $35.62
($33.37)
$ 34.182%Sold Out0
HAEKen Fisher 2014-06-30 Add$30.36 - $35.62
($33.37)
$ 34.182%Add 20.48%177,645
HAERobert Olstein 2014-06-30 Sold Out -0.06%$30.36 - $35.62
($33.37)
$ 34.182%Sold Out0
HAEJames Barrow 2014-03-31 Add0.1%$31.84 - $43.37
($38.44)
$ 34.18-11%Add 217.54%3,042,669
HAERobert Olstein 2014-03-31 Buy 0.06%$31.84 - $43.37
($38.44)
$ 34.18-11%New holding, 14400 sh.14,400
HAEJoel Greenblatt 2014-03-31 Buy 0.02%$31.84 - $43.37
($38.44)
$ 34.18-11%New holding, 42809 sh.42,809
HAEJames Barrow 2013-12-31 Buy 0.06%$38.87 - $43.83
($41.15)
$ 34.18-17%New holding, 958209 sh.958,209
HAEThird Avenue Management 2013-12-31 Sold Out -0.03%$38.87 - $43.83
($41.15)
$ 34.18-17%Sold Out0
HAEThird Avenue Management 2013-06-30 Reduce-0.01%$37.75 - $42.71
($40.49)
$ 34.18-16%Reduce -27.59%42,000
HAEKen Fisher 2013-03-31 Add$40.78 - $44.44
($41.8)
$ 34.18-18%Add 26.97%166,920
HAEThird Avenue Management 2013-03-31 Reduce-0.02%$40.78 - $44.44
($41.8)
$ 34.18-18%Reduce -25.64%58,000
HAEMeridian Funds 2012-12-31 Add0.29%$38.92 - $41.38
($40.27)
$ 34.18-15%Add 100%354,600
HAEKen Fisher 2012-12-31 Add0.01%$38.92 - $41.38
($40.27)
$ 34.18-15%Add 104.06%131,465
HAEJean-Marie Eveillard 2012-12-31 Add$38.92 - $41.38
($40.27)
$ 34.18-15%Add 100%8,000
HAEThird Avenue Management 2012-12-31 Reduce-0.17%$38.92 - $41.38
($40.27)
$ 34.18-15%Reduce -53.77%78,000
HAEMeridian Funds 2012-09-30 Add0.09%$68.61 - $81.4
($74.4)
$ 34.18-54%Add 21.86%177,300
HAEThird Avenue Management 2012-09-30 Reduce-0.29%$68.61 - $81.4
($74.4)
$ 34.18-54%Reduce -49.31%168,722
HAEMeridian Funds 2012-06-30 Buy 0.36%$66.79 - $73.87
($69.93)
$ 34.18-51%New holding, 145500 sh.145,500
HAEKen Fisher 2012-03-31 Reduce$61.85 - $70.45
($62.3)
$ 34.18-45%Reduce -20.62%56,025
HAEJoel Greenblatt 2012-03-31 Sold Out -0.12%$61.85 - $70.45
($62.3)
$ 34.18-45%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HAE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HAE Ken Fisher 2014-06-30177,6450.350.01+20.48%
HAE James Barrow 2014-06-302,926,5245.690.14-3.82%
HAE Joel Greenblatt 2014-06-3038,5900.080.02-9.86%
HAE Robert Olstein 2014-06-30000Sold Out
HAE Jean-Marie Eveillard 2014-06-30000Sold Out
HAE Meridian Funds 2013-06-30439,5000.850.68+12.55%
Premium Most recent portfolio changes are included for Premium Members only!


HAE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ALLEN PETER MPresident, Global Plasma 2014-10-13Sell36,426$35.22-2.33view
McDaniel KathleenEVP Global Human Resources 2014-08-28Sell406$35.46-2.99view
MERRIMAN RONALDDirector 2014-08-12Sell13,602$35.76-3.8view
CONCANNON BRIANPresident & CEO 2014-08-01Sell4,380$35.27-2.47view
GRANADILLO PEDRO PDirector 2014-07-07Sell5,837$35.97-4.36view
CONCANNON BRIANPresident & CEO 2014-07-01Sell4,600$35.83-3.99view
BEST LAWRENCE CDirector 2014-06-12Sell9,184$33.911.45view
GELBMAN RONALD GDirector 2014-06-12Sell9,184$341.18view
GRANADILLO PEDRO PDirector 2014-06-06Sell5,837$34.69-0.84view
CONCANNON BRIANPresident & CEO 2014-06-02Sell4,600$33.542.56view

Press Releases about HAE :

    Quarterly/Annual Reports about HAE:

    News about HAE:

    Articles On GuruFocus.com
    Meridian Contrarian Fund Second Quarter Commentary Sep 08 2014 
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    The Olstein All Cap Value Fund’s 2014 First Quarter Letter to Shareholders Jul 22 2014 
    This Blood Management Company Can Be A Safe Investment Jul 13 2014 
    Meridian Funds Comments on Haemonetics Aug 28 2013 
    Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
    Weeky CFO Sells Highlight: ADBE, HAE, WAGE, OVTI, ICPT Jun 24 2013 
    Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
    Weekly Guru Bargains Highlights: HAE, DLTR, QCOR, MTX, AMD Jan 21 2013 
    Weekly Guru Bargains Highlights: CIG, ARO, NKE, DLTR, HAE Jan 13 2013 

    More From Other Websites
    3PEA International and Haemonetics Partner to Integrate PaySign Connect with Haemonetics’ Donor... Oct 21 2014
    Haemonetics Sets Date for Second Quarter Fiscal Year 2015 Earnings Release: November 3, 2014 Oct 06 2014
    Perrigo Sells Some Assets to Imago Pharmaceuticals Oct 03 2014
    Data Intensity Fortifies Track Record of Success in Oracle EBS R12 Implementations and Upgrades Sep 23 2014
    HAEMONETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Sep 22 2014
    Haemonetics (HAE) Poised on Strong Q2, Optimistic Outlook Sep 19 2014
    Insider Trading Alert - TUP, HAE And SNI Traded By Insiders Sep 03 2014
    Haemonetics to Present at Morgan Stanley's Global Healthcare Conference Aug 22 2014
    HAEMONETICS CORP Financials Aug 08 2014
    Haemonetics Tops Q1 Earnings and Revenues, Guidance Retained Aug 01 2014
    Wall Street Transcript Interview with Christopher Clark, the CFO of Neovasc Inc. (NVCN) Aug 01 2014
    HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report Jul 31 2014
    Q1 2015 Haemonetics Corporation Earnings Release - Before Market Open Jul 30 2014
    HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 30 2014
    Haemonetics Reports 1st Quarter Fiscal 2015 Revenue of $224 Million and Adjusted EPS of $0.38,... Jul 30 2014
    HAEMONETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors... Jul 25 2014
    Charles J. Dockendorff Joins Haemonetics Board of Directors Jul 23 2014
    HAEMONETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jul 07 2014
    Haemonetics (HAE) is in Overbought Territory: What's Next? Jun 30 2014
    Haemonetics Sets Date for First Quarter Fiscal Year 2015 Earnings Release: July 30, 2014 Jun 30 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK